BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cai XC, Wu SD. Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review. World J Clin Cases 2022; 10(23): 8212-8223 [PMID: 36159526 DOI: 10.12998/wjcc.v10.i23.8212]
URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8212.htm
Number Citing Articles
1
Chao Li, Pan Lv, Liu Yanyan, Maohui Yin, Hao Li. Immune checkpoint inhibitor therapy for primary neuroendocrine carcinoma of the gallbladder: A case report and literature reviewMedicine 2024; 103(43): e40178 doi: 10.1097/MD.0000000000040178
2
Jin-Xiu Wu, Rong Hua, Xiang-Ji Luo, Feng Xie, Li Yao. Effects of cytoreductive surgery combined with hyperthermic perfusion chemotherapy on prognosis of patients with advanced gallbladder cancerWorld Journal of Gastrointestinal Surgery 2023; 15(11): 2413-2422 doi: 10.4240/wjgs.v15.i11.2413
3
Feizhuan Lin. Long-term survival of neuroendocrine carcinoma of the gallbladder with surgical removal aloneAsian Journal of Surgery 2024; 47(1): 628 doi: 10.1016/j.asjsur.2023.09.139
4
Zhi-Hao Zhao, Yu Huang, Chao Jiang, Guo-Yue Lv, Meng Wang. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomasFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1326112
5
Ya-Fei Hu, Jun-Ke Wang, Wen-Jie Ma, Hai-Jie Hu, Han-Fei Gu, Fei Liu, Tian-Run Lv, Si-Qi Yang, Yu-Shi Dai, Rui-Qi Zou, Yan-Wen Jin, Fu-Yu Li. Does the size of the neuroendocrine-carcinoma component determine the prognosis of gallbladder cancer?Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1217250
6
Xiaofei Yao, Kangze Wu, Baochun Lu, Feizhuan Lin. Neuroendocrine carcinoma of the gallbladder: A case report and literature reviewMedicine 2024; 103(31): e39147 doi: 10.1097/MD.0000000000039147